460 related articles for article (PubMed ID: 28276853)
1. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
Sultan A; Choudhary V; Parganiha A
Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization-induced exacerbation of the ill effects of chemotherapy on rest-activity rhythm and quality of life of breast cancer patients: a prospective and comparative cross-sectional follow-up study.
Sultan A; Pati AK; Choudhary V; Parganiha A
Chronobiol Int; 2018 Oct; 35(11):1513-1532. PubMed ID: 29985659
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients.
Pati AK; Parganiha A; Kar A; Soni R; Roy S; Choudhary V
Chronobiol Int; 2007; 24(6):1179-97. PubMed ID: 18075806
[TBL] [Abstract][Full Text] [Related]
4. Effect of hospitalization on rest-activity rhythm and quality of life of cancer patients.
Parganiha A; Taj S; Chandel P; Sultan A; Choudhary V
Indian J Exp Biol; 2014 May; 52(5):549-58. PubMed ID: 24851420
[TBL] [Abstract][Full Text] [Related]
5. Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer.
Fatiregun OA; Olagunju AT; Erinfolami AR; Arogunmati OA; Fatiregun OA; Adeyemi JD
Breast; 2017 Feb; 31():150-156. PubMed ID: 27866090
[TBL] [Abstract][Full Text] [Related]
6. The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy.
Ortiz-Tudela E; Iurisci I; Beau J; Karaboue A; Moreau T; Rol MA; Madrid JA; Lévi F; Innominato PF
Int J Cancer; 2014 Jun; 134(11):2717-25. PubMed ID: 24510611
[TBL] [Abstract][Full Text] [Related]
7. Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
Schmid P; Lipatov O; Im SA; Goncalves A; Muñoz-Couselo E; Lee KS; Tamura K; Testa L; Witzel I; Ohtani S; Turner N; Zambelli S; Harbeck N; Andre F; Dent R; Mejia JA; Zhou X; Haiderali A; Nguyen AM; Cortes J; Winer EP
Eur J Cancer; 2023 Dec; 195():113393. PubMed ID: 37976633
[TBL] [Abstract][Full Text] [Related]
8. Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer.
Innominato PF; Komarzynski S; Palesh OG; Dallmann R; Bjarnason GA; Giacchetti S; Ulusakarya A; Bouchahda M; Haydar M; Ballesta A; Karaboué A; Wreglesworth NI; Spiegel D; Lévi FA
Cancer Med; 2018 Sep; 7(9):4396-4405. PubMed ID: 30088335
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
[TBL] [Abstract][Full Text] [Related]
10. Associations between Diabetes and Quality of Life among Breast Cancer Survivors.
Tang Z; Wang J; Zhang H; Sun L; Tang F; Deng Q; Yu J
PLoS One; 2016; 11(6):e0157791. PubMed ID: 27333326
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the rest-activity circadian rhythm to quality of life in cancer patients.
Mormont MC; Waterhouse J
Chronobiol Int; 2002 Jan; 19(1):313-23. PubMed ID: 11962684
[TBL] [Abstract][Full Text] [Related]
12. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
[TBL] [Abstract][Full Text] [Related]
13. Rest-activity circadian rhythm and sleep quality in patients with binge eating disorder.
Roveda E; Montaruli A; Galasso L; Pesenti C; Bruno E; Pasanisi P; Cortellini M; Rampichini S; Erzegovesi S; Caumo A; Esposito F
Chronobiol Int; 2018 Feb; 35(2):198-207. PubMed ID: 29144185
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract][Full Text] [Related]
15. Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial.
Hurvitz SA; Quek RGW; Turner NC; Telli ML; Rugo HS; Mailliez A; Ettl J; Grischke E; Mina LA; Balmaña J; Fasching PA; Bhattacharyya H; Hannah AL; Robson ME; Wardley AM
Eur J Cancer; 2018 Nov; 104():160-168. PubMed ID: 30359909
[TBL] [Abstract][Full Text] [Related]
16. [Quality of life in Mexican women with breast cancer at different stages and its association with sociodemographic characteristics, comorbidities and procedural factors at the Mexican Institute of Social Security].
Sat-Muñoz D; Contreras-Hernández I; Balderas-Peña LM; Hernández-Chávez GA; Solano-Murillo P; Mariscal-Ramírez I; Lomelí-García M; Díaz-Cortés MA; Mould-Quevedo JF; López-Mariscal AR; Prieto-Miranda SE; Morgan-Villela G
Value Health; 2011; 14(5 Suppl 1):S133-6. PubMed ID: 21839887
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
Hassen AM; Taye G; Gizaw M; Hussien FM
PLoS One; 2019; 14(9):e0222629. PubMed ID: 31539399
[TBL] [Abstract][Full Text] [Related]
18. Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer.
Berger AM; Grem JL; Visovsky C; Marunda HA; Yurkovich JM
Oncol Nurs Forum; 2010 Nov; 37(6):E359-69. PubMed ID: 21059569
[TBL] [Abstract][Full Text] [Related]
19. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.
Berger AM; Wielgus K; Hertzog M; Fischer P; Farr L
Support Care Cancer; 2010 Jan; 18(1):105-14. PubMed ID: 19381692
[TBL] [Abstract][Full Text] [Related]
20. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
